Patterns of steroid use in diarrhoea and/or colitis (D/C) from immune checkpoint inhibitors (ICPI)

Authors:
  • LSL. Spain
    L. Spain
  • SDS. Diem
    S. Diem
  • KKK. Khabra
    K. Khabra
  • STS. Turajlic
    S. Turajlic
  • MGM. Gore
    M. Gore
  • NYN. Yousaf
    N. Yousaf

Abstract
Background: D/C is reported in up to 30% of patients treated with ICPI. Treatment algorithms advocate corticosteroids (CS) for moderate to severe symptoms. Patterns of endoscopic change and duration of CS are not described. Rates of CS toxicity in this group of patients are unclear.